What is the treatment for status asthmaticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Status Asthmaticus

The treatment of status asthmaticus requires immediate administration of high-flow oxygen, inhaled short-acting beta-agonists (salbutamol 5 mg or terbutaline 10 mg via nebulizer), and systemic corticosteroids (prednisolone 30-60 mg or IV hydrocortisone 200 mg). 1

Initial Assessment and Management

Recognition of Status Asthmaticus

  • Unable to complete sentences in one breath 1
  • Respiratory rate >25 breaths/min in adults, >50 breaths/min in children 1
  • Heart rate >110 beats/min in adults, >140 beats/min in children 1
  • Peak Expiratory Flow (PEF) <50% of predicted or best 1
  • Life-threatening features: PEF <33% predicted, silent chest, cyanosis, poor respiratory effort, exhaustion, confusion, or coma 1

Immediate Treatment

  • High-flow oxygen (40-60%) via face mask to maintain SaO₂ >92% 1, 2
  • Nebulized short-acting beta-agonists: salbutamol 5 mg or terbutaline 10 mg (half doses for young children) 1
  • Systemic corticosteroids: prednisolone 30-60 mg orally or hydrocortisone 200 mg IV 1, 3
  • Add ipratropium bromide 0.5 mg to nebulizer (100 μg in children) and repeat every 6 hours 1

Ongoing Management

For Patients Showing Improvement

  • Continue high-flow oxygen 1, 3
  • Prednisolone 1-2 mg/kg daily (maximum 40 mg in children) 1
  • Nebulized beta-agonists every 4 hours 1
  • Monitor PEF before and after bronchodilator treatment 1

For Patients Not Improving After 15-30 Minutes

  • Continue oxygen and steroids 1
  • Increase frequency of nebulized beta-agonists up to every 15-30 minutes 1
  • Consider IV magnesium sulfate for life-threatening exacerbations or those remaining severe after 1 hour of intensive treatment 1, 4
  • For life-threatening features in children: IV aminophylline 5 mg/kg over 20 minutes followed by maintenance infusion of 1 mg/kg/h (omit loading dose if already on oral theophyllines) 1

Criteria for ICU Transfer

  • Deteriorating PEF despite treatment 1
  • Persistent or worsening hypoxia 1, 5
  • Hypercapnia (PaCO₂ ≥42 mm Hg) 1, 5
  • Exhaustion, confusion, drowsiness 1
  • Respiratory arrest or coma 1

Mechanical Ventilation Considerations

  • If pharmacological therapy fails to reverse severe airflow obstruction, mechanical ventilation may be required 6, 5
  • Ventilation strategy should avoid excessive lung inflation by limiting minute ventilation and prolonging expiratory time, despite resulting hypercapnia 6, 5
  • Sedation may be required but paralytic agents should be avoided if possible due to risk of ICU myopathy 6, 5

Discharge Criteria and Follow-up

  • Patient should be on discharge medication for 24 hours with inhaler technique checked and recorded 1
  • PEF >75% of predicted or best with diurnal variability <25% 1
  • Treatment plan should include oral and inhaled corticosteroids, bronchodilators, and a written self-management plan 1
  • Follow-up with primary care within 1 week 1
  • Specialist respiratory clinic follow-up within 4 weeks 1

Common Pitfalls to Avoid

  • Delaying corticosteroid administration - should be given immediately as effects take 6-12 hours to manifest 3, 7
  • Using sedatives in asthmatic patients - contraindicated due to risk of respiratory depression 2, 6
  • Administering antibiotics without clear evidence of bacterial infection 2, 6
  • Underestimating severity - many deaths occur due to failure to recognize severity 1, 6
  • Discharging patients too early - ensure adequate response to treatment and appropriate follow-up plans 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento Farmacológico en Crisis Asmática

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of respiratory failure in status asthmaticus.

American journal of respiratory medicine : drugs, devices, and other interventions, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.